Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas F Brown

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Theranostics|March 21, 2020
Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virusKate M Moore, Ami Desai, Bea de Luxán Delgado, et al.
Journal of Medicinal Chemistry|February 2, 2023
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open ScienceSven Thamm, Marina K Willwacher, Gary E Aspnes, et al.
British Journal of Cancer|August 4, 2020
Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumoursRebecca Kristeleit, Jeffry Evans, L Rhoda Molife, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2017
Dihydrobenzisoxazole-4-one compounds are novel selective inhibitors of aldosterone synthase (CYP11B2) with in vivo activityKenneth Meyers, Derek A Cogan, Jennifer Burke, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Theranostics|March 21, 2020
Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virusKate M Moore, Ami Desai, Bea de Luxán Delgado, et al.
Journal of Medicinal Chemistry|February 2, 2023
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open ScienceSven Thamm, Marina K Willwacher, Gary E Aspnes, et al.
British Journal of Cancer|August 4, 2020
Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumoursRebecca Kristeleit, Jeffry Evans, L Rhoda Molife, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2017
Dihydrobenzisoxazole-4-one compounds are novel selective inhibitors of aldosterone synthase (CYP11B2) with in vivo activityKenneth Meyers, Derek A Cogan, Jennifer Burke, et al.
Pageof 4